NR 546 FINAL EXAM PRACTICE | STUDY GUIDE | TESTBANK | PRACTICE
QUESTIONS & ANSWERS | EXAM PREPARATION | ADVANCED REVIEW |
COMPREHENSIVE PRACTICE EXAM | LATEST UPDATE 2026/2027
Examiner:
Chamberlain University College of Nursing
TABLE OF CONTENTS
1. Advanced Pharmacotherapeutics Principles
2. Pharmacokinetics and Pharmacodynamics
3. Evidence-Based Prescribing
4. Drug Selection Across the Lifespan
5. Management of Chronic Diseases
6. Infectious Diseases and Antimicrobial Stewardship
7. Endocrine Disorders
8. Cardiovascular Pharmacotherapy
9. Respiratory Disorders
10. Neurologic and Psychiatric Pharmacology
11. Women's and Men's Health Pharmacotherapy
12. Clinical Decision-Making and Patient Safety
DESCRIPTION
This comprehensive practice question set is designed to help students prepare for
advanced pharmacology concepts commonly emphasized in graduate nursing
pharmacotherapeutics courses. The questions emphasize clinical reasoning, patient
assessment, medication selection, safety monitoring, adverse effect recognition,
evidence-based prescribing, and individualized treatment planning across diverse
patient populations. Learners will encounter complex clinical scenarios requiring
interpretation of laboratory findings, consideration of comorbidities, contraindications,
drug interactions, therapeutic monitoring, and professional judgment. The content
reflects the scope typically covered in advanced nurse practitioner pharmacology
coursework and serves as a challenging study resource for reviewing essential
concepts before comprehensive examinations. These practice questions are intended
,solely as educational study material and are not actual examination questions or
replicas of any official examination.
QUESTION 1.
A 67-year-old patient with type 2 diabetes, hypertension, and stage 3 chronic
kidney disease requires an additional antihyperglycemic medication despite
optimized metformin therapy. Which medication is most likely to provide both
glycemic control and evidence-based cardiovascular and renal protection?
A. Sulfonylurea
B. DPP-4 inhibitor
C. SGLT2 inhibitor
D. Meglitinide
🔴 Correct Answer: C. SGLT2 inhibitor
🔵 Explanation: SGLT2 inhibitors have demonstrated reductions in cardiovascular
events and slowing of chronic kidney disease progression in appropriate patients
while improving glycemic control. Sulfonylureas and meglitinides primarily lower
glucose without comparable renal or cardiovascular benefits and carry greater
hypoglycemia risk. DPP-4 inhibitors generally have neutral cardiovascular outcomes.
QUESTION 2.
A patient receiving warfarin develops a bacterial infection and is prescribed an
antibiotic. Which prescribing decision best demonstrates safe clinical judgment?
A. Continue warfarin without additional monitoring.
B. Assess for clinically significant drug interactions and increase INR monitoring.
C. Discontinue warfarin permanently.
D. Double the warfarin dose to compensate for infection.
🔴 Correct Answer: B. Assess for clinically significant drug interactions and
increase INR monitoring.
,🔵 Explanation: Numerous antibiotics alter warfarin metabolism or intestinal vitamin
K production, increasing bleeding risk. Enhanced INR monitoring allows individualized
dose adjustment. Automatically stopping warfarin or increasing the dose is not
appropriate without clinical indication.
QUESTION 3.
A patient with uncontrolled hypertension reports persistent use of ibuprofen for
chronic osteoarthritis pain. Which explanation best accounts for worsening blood
pressure control?
A. NSAIDs commonly reduce the effectiveness of many antihypertensive
medications.
B. Ibuprofen directly increases insulin resistance.
C. NSAIDs stimulate excessive thyroid hormone production.
D. Ibuprofen permanently damages vascular receptors after short-term use.
🔴 Correct Answer: A. NSAIDs commonly reduce the effectiveness of many
antihypertensive medications.
🔵 Explanation: NSAIDs promote sodium and water retention while reducing renal
prostaglandin synthesis, potentially increasing blood pressure and decreasing
antihypertensive efficacy. The remaining options do not adequately explain the
clinical scenario.
QUESTION 4.
A patient newly diagnosed with atrial fibrillation has normal renal function and no
contraindications to anticoagulation. Current evidence most strongly supports
which initial strategy for reducing stroke risk?
A. Aspirin alone
B. Dual antiplatelet therapy
C. No pharmacologic therapy until symptoms worsen
D. Appropriate oral anticoagulation based on stroke-risk assessment
, 🔴 Correct Answer: D. Appropriate oral anticoagulation based on stroke-risk
assessment
🔵 Explanation: Stroke prevention in atrial fibrillation is guided by validated risk
assessment and generally favors oral anticoagulation for eligible patients. Aspirin and
dual antiplatelet therapy provide substantially less protection against cardioembolic
stroke.
QUESTION 5.
A patient taking levothyroxine reports continued hypothyroid symptoms despite
adherence. Which additional history is most important before adjusting the
dosage?
A. Frequency of sunscreen use
B. Timing of levothyroxine administration relative to meals and supplements
C. Daily water intake
D. Preferred exercise routine
🔴 Correct Answer: B. Timing of levothyroxine administration relative to meals
and supplements
🔵 Explanation: Levothyroxine absorption is significantly affected by food, calcium,
iron, and several medications. Evaluating administration technique is essential before
increasing the dose. The other factors are unlikely to explain inadequate therapeutic
response.
QUESTION 6.
A nurse practitioner is evaluating whether to prescribe an ACE inhibitor for a patient
with diabetes and albuminuria. Which rationale best supports this choice?
A. ACE inhibitors eliminate the need for glucose monitoring.
B. ACE inhibitors reduce progression of diabetic kidney disease in appropriate
patients.
QUESTIONS & ANSWERS | EXAM PREPARATION | ADVANCED REVIEW |
COMPREHENSIVE PRACTICE EXAM | LATEST UPDATE 2026/2027
Examiner:
Chamberlain University College of Nursing
TABLE OF CONTENTS
1. Advanced Pharmacotherapeutics Principles
2. Pharmacokinetics and Pharmacodynamics
3. Evidence-Based Prescribing
4. Drug Selection Across the Lifespan
5. Management of Chronic Diseases
6. Infectious Diseases and Antimicrobial Stewardship
7. Endocrine Disorders
8. Cardiovascular Pharmacotherapy
9. Respiratory Disorders
10. Neurologic and Psychiatric Pharmacology
11. Women's and Men's Health Pharmacotherapy
12. Clinical Decision-Making and Patient Safety
DESCRIPTION
This comprehensive practice question set is designed to help students prepare for
advanced pharmacology concepts commonly emphasized in graduate nursing
pharmacotherapeutics courses. The questions emphasize clinical reasoning, patient
assessment, medication selection, safety monitoring, adverse effect recognition,
evidence-based prescribing, and individualized treatment planning across diverse
patient populations. Learners will encounter complex clinical scenarios requiring
interpretation of laboratory findings, consideration of comorbidities, contraindications,
drug interactions, therapeutic monitoring, and professional judgment. The content
reflects the scope typically covered in advanced nurse practitioner pharmacology
coursework and serves as a challenging study resource for reviewing essential
concepts before comprehensive examinations. These practice questions are intended
,solely as educational study material and are not actual examination questions or
replicas of any official examination.
QUESTION 1.
A 67-year-old patient with type 2 diabetes, hypertension, and stage 3 chronic
kidney disease requires an additional antihyperglycemic medication despite
optimized metformin therapy. Which medication is most likely to provide both
glycemic control and evidence-based cardiovascular and renal protection?
A. Sulfonylurea
B. DPP-4 inhibitor
C. SGLT2 inhibitor
D. Meglitinide
🔴 Correct Answer: C. SGLT2 inhibitor
🔵 Explanation: SGLT2 inhibitors have demonstrated reductions in cardiovascular
events and slowing of chronic kidney disease progression in appropriate patients
while improving glycemic control. Sulfonylureas and meglitinides primarily lower
glucose without comparable renal or cardiovascular benefits and carry greater
hypoglycemia risk. DPP-4 inhibitors generally have neutral cardiovascular outcomes.
QUESTION 2.
A patient receiving warfarin develops a bacterial infection and is prescribed an
antibiotic. Which prescribing decision best demonstrates safe clinical judgment?
A. Continue warfarin without additional monitoring.
B. Assess for clinically significant drug interactions and increase INR monitoring.
C. Discontinue warfarin permanently.
D. Double the warfarin dose to compensate for infection.
🔴 Correct Answer: B. Assess for clinically significant drug interactions and
increase INR monitoring.
,🔵 Explanation: Numerous antibiotics alter warfarin metabolism or intestinal vitamin
K production, increasing bleeding risk. Enhanced INR monitoring allows individualized
dose adjustment. Automatically stopping warfarin or increasing the dose is not
appropriate without clinical indication.
QUESTION 3.
A patient with uncontrolled hypertension reports persistent use of ibuprofen for
chronic osteoarthritis pain. Which explanation best accounts for worsening blood
pressure control?
A. NSAIDs commonly reduce the effectiveness of many antihypertensive
medications.
B. Ibuprofen directly increases insulin resistance.
C. NSAIDs stimulate excessive thyroid hormone production.
D. Ibuprofen permanently damages vascular receptors after short-term use.
🔴 Correct Answer: A. NSAIDs commonly reduce the effectiveness of many
antihypertensive medications.
🔵 Explanation: NSAIDs promote sodium and water retention while reducing renal
prostaglandin synthesis, potentially increasing blood pressure and decreasing
antihypertensive efficacy. The remaining options do not adequately explain the
clinical scenario.
QUESTION 4.
A patient newly diagnosed with atrial fibrillation has normal renal function and no
contraindications to anticoagulation. Current evidence most strongly supports
which initial strategy for reducing stroke risk?
A. Aspirin alone
B. Dual antiplatelet therapy
C. No pharmacologic therapy until symptoms worsen
D. Appropriate oral anticoagulation based on stroke-risk assessment
, 🔴 Correct Answer: D. Appropriate oral anticoagulation based on stroke-risk
assessment
🔵 Explanation: Stroke prevention in atrial fibrillation is guided by validated risk
assessment and generally favors oral anticoagulation for eligible patients. Aspirin and
dual antiplatelet therapy provide substantially less protection against cardioembolic
stroke.
QUESTION 5.
A patient taking levothyroxine reports continued hypothyroid symptoms despite
adherence. Which additional history is most important before adjusting the
dosage?
A. Frequency of sunscreen use
B. Timing of levothyroxine administration relative to meals and supplements
C. Daily water intake
D. Preferred exercise routine
🔴 Correct Answer: B. Timing of levothyroxine administration relative to meals
and supplements
🔵 Explanation: Levothyroxine absorption is significantly affected by food, calcium,
iron, and several medications. Evaluating administration technique is essential before
increasing the dose. The other factors are unlikely to explain inadequate therapeutic
response.
QUESTION 6.
A nurse practitioner is evaluating whether to prescribe an ACE inhibitor for a patient
with diabetes and albuminuria. Which rationale best supports this choice?
A. ACE inhibitors eliminate the need for glucose monitoring.
B. ACE inhibitors reduce progression of diabetic kidney disease in appropriate
patients.
